Lymphoma Hub cover art

Lymphoma Hub

Lymphoma Hub

By: Scientific Education Support
Listen for free

The Lymphoma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in lymphoma and CLL. Our aim is to enhance knowledge in lymphoma and CLL, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.

Hosted on Acast. See acast.com/privacy for more information.

Scientific Education Support
Episodes
  • Zanubrutinib for patients with previously untreated CLL/SLL: Insights from the SEQUOIA trial

    Zanubrutinib for patients with previously untreated CLL/SLL: Insights from the SEQUOIA trial
    Jul 10 2026

    During the Lymphoma Hub Steering Committee Meeting on April 20, 2026, key opinion leaders met to discuss results from the long-term follow-up of the phase III SEQUOIA trial (NCT03336333) evaluating zanubrutinib in patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). The discussion was chaired by Jacob Soumerai and featured Gilles Salles, Ulrich Jäger, Sonali Smith, Martin Dreyling, Astrid Pavlovsky, Michael Dickinson, and Jennifer Crombie.


    Soumerai presented an overview of the SEQUOIA trial, efficacy and safety data, and key takeaways.


    This educational resource is independently supported by BeOne Medicines. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    27 mins
  • EHA 2026 | What are the key findings from the phase I ANTLER trial in R/R B-cell NHL?

    EHA 2026 | What are the key findings from the phase I ANTLER trial in R/R B-cell NHL?
    Jul 1 2026

    During the European Hematology Association (EHA) 2026 Congress, June 11–14, 2025, Stockholm, SE, the Lymphoma Hub spoke with Stephen Schuster, University of Pennsylvania, Philadelphia, US. We asked, What are the key findings from the phase I ANTLER trial in R/R B-cell NHL?


    This educational resource is independently supported by Caribou Biosciences. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    5 mins
  • Annual oncology meeting | Key highlights in lymphoma

    Annual oncology meeting | Key highlights in lymphoma
    Jun 22 2026
    During the American Society of Clinical Oncology Annual Meeting, May 19 – June 2, 2026, Chicago, US, the Lymphoma Hub was pleased to speak with Joshua Brody from the Icahn School of Medicine at Mount Sinai, New York, US.

    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
    11 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet